We are live on ! Find out more
RP

Rowlandmiller & Partners Portfolio holdings

AUM $549M
1-Year Est. Return 36.2%
This Fund
S&P 500
This Quarter Est. Return
+8.44%
1 Year Est. Return
+36.2%
3 Year Est. Return
+84%
5 Year Est. Return
+107.35%
10 Year Est. Return
+338.51%
AUM
$383M
AUM Growth
+$31.7M
Cap. Flow
+$6.16M
Cap. Flow %
1.61%
Top 10 Hldgs %
35.16%
Holding
176
New
16
Increased
57
Reduced
46
Closed
7

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$4.07M
2
TROW icon
T. Rowe Price
TROW
+$1.59M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.22M
4
VZ icon
Verizon
VZ
+$903K
5
GNTX icon
Gentex
GNTX
+$681K

Sector Composition

Rank Sector Weight
1 Technology 24%
2 Financials 14.36%
3 Healthcare 13.68%
4 Industrials 11.47%
5 Consumer Discretionary 10.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DIS icon
26
Walt Disney
DIS
$167B
$5.25M 1.37%
28,447
-504
-2% -$92.9K
CVX icon
27
Chevron
CVX
$392B
$4.9M 1.28%
46,806
+861
+2% +$84.1K
AMGN icon
28
Amgen
AMGN
$208B
$4.81M 1.26%
19,345
-115
-0.6% -$27.4K
ABBV icon
29
AbbVie
ABBV
$443B
$4.28M 1.12%
39,533
+38,090
+2,640% +$4.07M
CPRT icon
30
Copart
CPRT
$27B
$4.05M 1.06%
149,096
-1,172
-0.8% -$33K
SON icon
31
Sonoco
SON
$5.57B
$3.96M 1.03%
62,515
+2,841
+5% +$173K
TFX icon
32
Teleflex
TFX
$6.05B
$3.7M 0.97%
8,913
KMB icon
33
Kimberly-Clark
KMB
$36.3B
$3.7M 0.97%
26,591
-245
-0.9% -$32.5K
TROW icon
34
T. Rowe Price
TROW
$23.9B
$3.7M 0.97%
21,544
+9,693
+82% +$1.59M
CSX icon
35
CSX Corp
CSX
$93.4B
$3.69M 0.96%
114,858
+21
+0% +$641
MRK icon
36
Merck
MRK
$322B
$3.63M 0.95%
49,321
+1,056
+2% +$77.9K
PAYX icon
37
Paychex
PAYX
$41.6B
$3.22M 0.84%
32,870
+3,643
+12% +$336K
JPM icon
38
JPMorgan Chase
JPM
$935B
$3.05M 0.8%
20,013
PDCO
39
DELISTED
Patterson Companies, Inc.
PDCO
$2.96M 0.77%
92,730
-3,486
-4% -$111K
T icon
40
AT&T
T
$159B
$2.89M 0.76%
126,416
-3,336
-3% -$73.8K
MMS icon
41
Maximus
MMS
$3.17B
$2.88M 0.75%
32,341
+2,106
+7% +$172K
CMP icon
42
Compass Minerals
CMP
$1.23B
$2.68M 0.7%
42,775
+690
+2% +$44.2K
SWKS icon
43
Skyworks Solutions
SWKS
$9.37B
$2.57M 0.67%
14,032
+731
+5% +$127K
DUK icon
44
Duke Energy
DUK
$97.8B
$2.51M 0.66%
26,009
+203
+0.8% +$18.5K
EMR icon
45
Emerson Electric
EMR
$83.9B
$2.49M 0.65%
27,544
+840
+3% +$72.3K
COP icon
46
ConocoPhillips
COP
$147B
$2.47M 0.64%
46,580
-355
-0.8% -$17.5K
PFE icon
47
Pfizer
PFE
$143B
$2.45M 0.64%
67,665
+3,271
+5% +$116K
GILD icon
48
Gilead Sciences
GILD
$162B
$2.27M 0.59%
35,085
+5,216
+17% +$336K
COST icon
49
Costco
COST
$422B
$2.24M 0.59%
6,353
+6
+0.1% +$2.09K
CTAS icon
50
Cintas
CTAS
$81.9B
$2.2M 0.57%
25,772
-60
-0.2% -$5.08K

Similar funds

Rowlandmiller & Partners's Q1 2021 Portfolio in Review

As of Q1 2021, Rowlandmiller & Partners held 176 positions worth $383M, up 9% from $351M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Rowlandmiller & Partners's Q1 2021 filing shows 16 new, 57 increased, 46 reduced and 7 closed positions. Its largest new stake was Expeditors International: 6,939 shares worth $747K. The largest sale was Dentsply Sirona, an estimated $2.71M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.

  • Rowlandmiller & Partners's largest Q1 2021 buy was Expeditors International: 6,939 shares worth $747K.
  • Rowlandmiller & Partners added most to AbbVie in Q1 2021, an estimated $4.07M increase.
  • Rowlandmiller & Partners's biggest Q1 2021 reduction was Dentsply Sirona, cutting an estimated $2.71M.
  • Rowlandmiller & Partners fully exited Maxim Integrated Products in Q1 2021, selling an estimated $653K.
  • Rowlandmiller & Partners's ten largest holdings make up 35% of its $383M portfolio in Q1 2021.
  • Rowlandmiller & Partners opened 16 new positions and closed 7 in Q1 2021.
  • Rowlandmiller & Partners's portfolio value rose 9% quarter-over-quarter to $383M.

Based on Rowlandmiller & Partners's 13F filing for Q1 2021, filed 11 May 2021.